KORRO BIO INC (KRRO)
US5009461089 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to KRRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 132.6. This target is 142.59% above the current price.
KRRO was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about KRRO.
In the previous month the buy percentage consensus was at a similar level.
KRRO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-15 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-26 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-03-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-27 | BMO Capital | Initiate | Outperform |
| 2024-01-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-04 | HC Wainwright & Co. | Initiate | Buy |
| 2023-11-29 | RBC Capital | Initiate | Outperform |
| 2023-11-10 | Piper Sandler | Initiate | Overweight |